Before starting microdosing, consult with your healthcare provider to ensure safety
These approaches should be viewed as complementary to, not replacements for, medical treatment when indicated, and may not produce significant GLP-1-mediated clinical effects on their own
By inhibiting oxidative phosphorylation (OXPHOS), which induces mitochondrial hyperpolarization and subsequently stimulates ROS production [23], the oxidation of palmitoylcarnitine (C16-carnitine) produces more ROS in mitochondria than carbohydrates [24]
PlexusDx providers review your current metformin dose and kidney function before recommending tirzepatide initiation, typically starting tirzepatide at a low dose while continuing your metformin regimen
If youre dealing with GLP-1 hair loss, its likely not because of any chemical interaction between the drug and your body
Those people may have already been at a higher risk of developing NAION, which could explain the higher numbers of the condition in this group, he says